Will risk compensation accompany pre-exposure prophylaxis for HIV?

Virtual Mentor. 2014 Nov 1;16(11):909-15. doi: 10.1001/virtualmentor.2014.16.11.stas1-1411.

Authors

Jill Blumenthal¹, Richard H Haubrich²

Affiliations

¹ Assistant clinical professor in the Division of Infectious Diseases in the Department of Medicine and a postdoctoral fellow studying HIV at the University of California, San Diego (UCSD) in La Jolla.
² Professor of medicine in the Division of Infectious Diseases in the Department of Medicine at the University of California, San Diego (UCSD) in La Jolla.

PMID: 25397651
PMCID: PMC4308722
DOI: 10.1001/virtualmentor.2014.16.11.stas1-1411

No abstract available

MeSH terms

Anti-HIV Agents / therapeutic use
HIV Infections / prevention & control*
Humans
Pre-Exposure Prophylaxis*
Risk-Taking
Unsafe Sex / psychology

Substances

Anti-HIV Agents

Grants and funding

K24 AI064086/AI/NIAID NIH HHS/United States